http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112521400-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5365 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-04 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20 |
filingDate | 2020-09-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2022-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2022-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-112521400-B |
titleOfInvention | A crystal form of hepatitis B surface antigen inhibitor and its application |
abstract | The invention discloses a crystal form of a hepatitis B surface antigen inhibitor and a preparation method thereof, and also includes the application of the crystal form in the preparation of the hepatitis B surface antigen inhibitor. |
priorityDate | 2019-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 284.